Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Marsden

Showing results (81-90 of 145) with videos related to

Pageof 15
Sort By:
The Lancet. Public Health|July 30, 2022
Policies and interventions to reduce harmful gambling: an international Delphi consensus and implementation rating studyMarguerite Regan, Maria Smolar, Robyn Burton, et al.
The Lancet Regional Health. Europe|May 10, 2021
The hospital admission profile of people presenting to specialist addiction services with problematic use of alcohol or opioids: A national retrospective cohort study in EnglandEmmert Roberts, Matthew Hotopf, John Strang, et al.
Addiction (Abingdon, England)|October 10, 2015
Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in EnglandMatthias Pierce, Sheila M Bird, Matthew Hickman, et al.
Addiction (Abingdon, England)|September 12, 2008
Development of the Treatment Outcomes ProfileJohn Marsden, Michael Farrell, Colin Bradbury, et al.
Psychopharmacology|August 11, 2022
Lower buprenorphine elimination rate constant is associated with lower opioid useHesham Farouk Elarabi, Amanda J Lee, Abdu Adem, et al.
The International Journal on Drug Policy|November 21, 2017
Effect of initiating drug treatment on the risk of drug-related poisoning death and acquisitive crime among offending heroin usersMatthias Pierce, Sheila M Bird, Matthew Hickman, et al.
Pharmacopsychiatry|January 31, 2020
Therapeutic Drug Monitoring in Buprenorphine/Naloxone Treatment for Opioid Use Disorder: Clinical Feasibility and Optimizing Assay PrecisionHesham Farouk Elarabi, Nael Hasan, John Marsden, et al.
Sleep|January 13, 2018
Development and early validation of a patient-reported outcome measure to assess sleep amongst people experiencing problems with alcohol or other drugsJoanne Neale, Silia Vitoratou, Paul Lennon, et al.
Addiction (Abingdon, England)|June 14, 2012
Risk adjustment of heroin treatment outcomes for comparative performance assessment in EnglandJohn Marsden, Brian Eastwood, Hayley Jones, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Memory-focused cognitive therapy for cocaine use disorder: Rationale, design and protocol for an external pilot randomised controlled trialJohn Marsden, Camille Goetz, Tim Meynen, et al.
Pageof 15

Showing results (81-90 of 145) with videos related to

Sort By:
Pageof 15
The Lancet. Public Health|July 30, 2022
Policies and interventions to reduce harmful gambling: an international Delphi consensus and implementation rating studyMarguerite Regan, Maria Smolar, Robyn Burton, et al.
The Lancet Regional Health. Europe|May 10, 2021
The hospital admission profile of people presenting to specialist addiction services with problematic use of alcohol or opioids: A national retrospective cohort study in EnglandEmmert Roberts, Matthew Hotopf, John Strang, et al.
Addiction (Abingdon, England)|October 10, 2015
Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in EnglandMatthias Pierce, Sheila M Bird, Matthew Hickman, et al.
Addiction (Abingdon, England)|September 12, 2008
Development of the Treatment Outcomes ProfileJohn Marsden, Michael Farrell, Colin Bradbury, et al.
Psychopharmacology|August 11, 2022
Lower buprenorphine elimination rate constant is associated with lower opioid useHesham Farouk Elarabi, Amanda J Lee, Abdu Adem, et al.
The International Journal on Drug Policy|November 21, 2017
Effect of initiating drug treatment on the risk of drug-related poisoning death and acquisitive crime among offending heroin usersMatthias Pierce, Sheila M Bird, Matthew Hickman, et al.
Pharmacopsychiatry|January 31, 2020
Therapeutic Drug Monitoring in Buprenorphine/Naloxone Treatment for Opioid Use Disorder: Clinical Feasibility and Optimizing Assay PrecisionHesham Farouk Elarabi, Nael Hasan, John Marsden, et al.
Sleep|January 13, 2018
Development and early validation of a patient-reported outcome measure to assess sleep amongst people experiencing problems with alcohol or other drugsJoanne Neale, Silia Vitoratou, Paul Lennon, et al.
Addiction (Abingdon, England)|June 14, 2012
Risk adjustment of heroin treatment outcomes for comparative performance assessment in EnglandJohn Marsden, Brian Eastwood, Hayley Jones, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Memory-focused cognitive therapy for cocaine use disorder: Rationale, design and protocol for an external pilot randomised controlled trialJohn Marsden, Camille Goetz, Tim Meynen, et al.
Pageof 15